- E-mailmarte.brattas@uib.no
- Visitor AddressHaukeland universitetssykehus, Laboratoriebygget5009 Bergen
- Postal AddressPostboks 78045020 Bergen
Academic article
- (2022). Heterogeneity of patient-derived acute myeloid leukemia cells subjected to SYK in vitro inhibition. International Journal of Molecular Sciences. 21 pages.
- (2019). Dasatinib is an investigational drug for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in adults. Expert Opinion on Investigational Drugs.
- (2019). Dasatinib as an investigational drug for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in adults. Expert Opinion on Investigational Drugs. 411-420.
- (2018). Philadelphia chromosome positive AML arising from JAK2-positive myelofibrosis. Biomarker Research.
- (2017). Ringsideroblaster. Tidsskrift for Den norske legeforening.
Academic literature review
- (2019). Precision medicine for TP53-mutated acute myeloid leukemia. Expert Review of Precision Medicine and Drug Development. 263-274.
- (2018). Splenic tyrosine kinase (SYK) inhibitors and their possible use in acute myeloid leukemia. Expert Opinion on Investigational Drugs. 377-387.
Article in business/trade/industry journal
- (2019). En kvinne i 40-?rene med bekkensmerter og uklare MR-funn. Tidsskrift for Den norske legeforening. 7 pages.
More information in national current research information system (CRIStin)